NCT05172284
Not yet recruiting
Not Applicable
Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases (IMIDs) REMIND Study
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio1 site in 1 country2,000 target enrollmentFebruary 2022
ConditionsImmuNe-Mediated Inflammatory Diseases
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- ImmuNe-Mediated Inflammatory Diseases
- Sponsor
- I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
- Enrollment
- 2000
- Locations
- 1
- Primary Endpoint
- Registry of ImmuNe-mediated inflammatory Diseases (IMIDs)
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies. This aim is achieved by evaluating the achievement of PASI 50 and PASI 75 scores at week 16 from the start of treatment.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with a diagnosis of IMID.
- •Patients of any age, including minors.
- •Patients treated with approved medications for the condition in question and/or phototherapy.
- •Patients who agree to sign informed consent.
Exclusion Criteria
- •Patients without a diagnosis of IMID.
- •Patients who do not consent to sign informed consent.
Outcomes
Primary Outcomes
Registry of ImmuNe-mediated inflammatory Diseases (IMIDs)
Time Frame: 15 years
Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies.
Secondary Outcomes
- PASI 75(15 years)
- PASI 50(15 years)
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA NephropathyIgA NephropathyNCT04438603Xinhua Hospital, Shanghai Jiao Tong University School of Medicine180
Completed
Not Applicable
Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported AssessmentInflammatory Bowel DiseasesCrohn DiseaseUlcerative ColitisIBDDigestive System DiseasePatient Reported Outcome MeasuresNCT04151420Maastricht University Medical Center584
Completed
Not Applicable
Idiopathic Pulmonary Fibrosis Registry for Future StudiesLung Disease, InterstitialIdiopathic Pulmonary FibrosisNCT00815711Ohio State University13
Recruiting
Not Applicable
IBD Registry in a Sub-Saharan African PopulationInflammatory Bowel DiseasesUlcerative ColitisCrohn DiseaseNCT04178408University of Zimbabwe100
Recruiting
Not Applicable
Immune Profiles Evolution Under Immunotherapy for MelanomaMelanomaNCT04576429Assistance Publique - Hôpitaux de Paris360